Analysts predict that Addus Homecare Co. (NASDAQ:ADUS) will report earnings of $0.47 per share for the current quarter, Zacks Investment Research reports. Four analysts have made estimates for Addus Homecare’s earnings. The highest EPS estimate is $0.51 and the lowest is $0.42. Addus Homecare reported earnings per share of $0.42 in the same quarter last year, which would suggest a positive year-over-year growth rate of 11.9%. The company is expected to issue its next earnings report on Monday, November 5th.

On average, analysts expect that Addus Homecare will report full-year earnings of $1.93 per share for the current financial year, with EPS estimates ranging from $1.80 to $2.01. For the next financial year, analysts anticipate that the firm will report earnings of $2.27 per share, with EPS estimates ranging from $2.03 to $2.54. Zacks’ EPS averages are a mean average based on a survey of sell-side analysts that follow Addus Homecare.

Addus Homecare (NASDAQ:ADUS) last announced its quarterly earnings data on Tuesday, August 7th. The company reported $0.50 EPS for the quarter, missing the Zacks’ consensus estimate of $0.51 by ($0.01). The firm had revenue of $131.24 million during the quarter, compared to analyst estimates of $127.81 million. Addus Homecare had a return on equity of 10.45% and a net margin of 3.43%.

A number of analysts recently commented on the company. BidaskClub lowered Addus Homecare from a “buy” rating to a “hold” rating in a research report on Saturday, September 22nd. Cantor Fitzgerald started coverage on Addus Homecare in a research report on Wednesday, September 12th. They set an “overweight” rating and a $77.00 target price for the company. ValuEngine upgraded Addus Homecare from a “buy” rating to a “strong-buy” rating in a research report on Tuesday, September 4th. Robert W. Baird restated a “hold” rating and set a $65.00 target price on shares of Addus Homecare in a research report on Wednesday, August 8th. Finally, Oppenheimer lifted their price objective on Addus Homecare from $50.00 to $72.00 and gave the company an “outperform” rating in a report on Wednesday, August 8th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Addus Homecare has an average rating of “Buy” and a consensus target price of $71.29.

ADUS stock traded down $1.75 during midday trading on Thursday, reaching $69.70. The stock had a trading volume of 138,800 shares, compared to its average volume of 89,309. The company has a quick ratio of 3.09, a current ratio of 3.09 and a debt-to-equity ratio of 0.53. The firm has a market cap of $922.18 million, a price-to-earnings ratio of 48.07, a PEG ratio of 2.89 and a beta of -0.38. Addus Homecare has a twelve month low of $30.95 and a twelve month high of $72.55.

In other Addus Homecare news, major shareholder Eos Capital Partners Iii L. P sold 1,024,733 shares of the business’s stock in a transaction that occurred on Monday, August 20th. The stock was sold at an average price of $59.00, for a total value of $60,459,247.00. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Insiders own 34.80% of the company’s stock.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Rhumbline Advisers lifted its stake in Addus Homecare by 14.5% in the 2nd quarter. Rhumbline Advisers now owns 7,630 shares of the company’s stock valued at $437,000 after acquiring an additional 964 shares in the last quarter. OppenheimerFunds Inc. increased its position in shares of Addus Homecare by 0.6% during the 1st quarter. OppenheimerFunds Inc. now owns 218,284 shares of the company’s stock worth $10,619,000 after purchasing an additional 1,300 shares during the last quarter. First Trust Advisors LP increased its position in shares of Addus Homecare by 18.9% during the 2nd quarter. First Trust Advisors LP now owns 8,480 shares of the company’s stock worth $485,000 after purchasing an additional 1,347 shares during the last quarter. Globeflex Capital L P increased its position in shares of Addus Homecare by 5.5% during the 2nd quarter. Globeflex Capital L P now owns 32,700 shares of the company’s stock worth $1,872,000 after purchasing an additional 1,700 shares during the last quarter. Finally, Wedge Capital Management L L P NC increased its position in shares of Addus Homecare by 7.5% during the 2nd quarter. Wedge Capital Management L L P NC now owns 27,778 shares of the company’s stock worth $1,590,000 after purchasing an additional 1,930 shares during the last quarter. Hedge funds and other institutional investors own 82.54% of the company’s stock.

Addus Homecare Company Profile

Addus HomeCare Corporation provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company's personal care services offer assistance with activities of daily living. Its services include assistance with bathing, grooming, oral care, assistance with feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services, as well as other activities of daily living.

Featured Story: NASDAQ

Get a free copy of the Zacks research report on Addus Homecare (ADUS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Addus Homecare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus Homecare and related companies with MarketBeat.com's FREE daily email newsletter.